Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
Saved in:
| Title: | Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients. |
|---|---|
| Authors: | Atanasova, Elena1 (AUTHOR), Milosevic, Dragana2 (AUTHOR), Bornschlegl, Svetlana1 (AUTHOR), Krucker, Karen P.3 (AUTHOR), Jacob, Eapen K.4 (AUTHOR), Carmona Porquera, Eva M.5 (AUTHOR), Anderson, Dagny K.5 (AUTHOR), Egan, Ashley M.5 (AUTHOR), Limper, Andrew H.5 (AUTHOR), Dietz, Allan B.1,3 (AUTHOR) Dietz.allan@mayo.edu |
| Source: | Stem Cell Research & Therapy. 1/31/2022, Vol. 13 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17576512 |
|---|---|
| DOI: | 10.1186/s13287-021-02692-0 |
